Indefinite Delivery Contract SPE2DU25D3310

The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), United States Coast Guard, and U.S. Naval Fleet. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.

The contract is an Indefinite Delivery Contract (IDC) with a 30-month base period and three 30-month option periods, for a total estimated value of $30.3 billion. The purpose is to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to support normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness (PVR), and War Readiness Materiel (WRM) for pharmaceutical (brand, generic, specialty) and pharmaceutical-related products. The contract encompasses a wide range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract will be awarded on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items, as well as a separate Back-Up Supplier award.